Latest Observability News

Alliance Nickel is advancing its NiWest project by exploring vat leaching to reduce capital costs and has completed initial gold drilling at Wanbanna, while continuing offtake talks with Stellantis and considering a NASDAQ listing via de-SPAC.

Tasman Resources reports progress on drilling preparations at its South Australian projects, with Fortescue-led heritage surveys set to unlock Titan West drilling this year, while Parkinson Dam faces scheduling delays.

Lodestar Minerals has intersected visible copper sulphides in its first diamond drill hole at the Three Saints project in Chile, hinting at a potentially significant IOCG-style mineralised system. Assay results are pending, with further drilling planned to explore the extent of mineralisation.

Kjerulf Ainsworth has launched a proportional all-cash takeover bid for 5.5% of Ainsworth Game Technology shares at a notable premium, aiming to provide liquidity and value to shareholders.

Torque Metals has appointed a seasoned leadership team from Spartan Resources to spearhead exploration and development at its Paris Gold Project near Kalgoorlie, backed by a $3 million capital raise.

Condor Energy has updated its corporate presentation revealing significant progress in Peru’s Tumbes Basin, highlighting a 1 trillion cubic feet gas discovery and a multi-billion barrel oil exploration portfolio. The company is moving towards converting its evaluation agreement into a full exploration licence while advancing commercial discussions for gas offtake.

Imugene Limited reports striking early results from its Phase 1b azer-cel trial, achieving a 100% overall response rate in chronic lymphocytic leukemia and 80% in marginal zone lymphoma, while broadening its study to include a BTK inhibitor combination.

Energy Transition Minerals' legal battle over the Kvanefjeld rare earths project moves from arbitration to Greenlandic and Danish courts, following a tribunal ruling that imposes significant costs on ETM's subsidiary.

Neometals has upgraded the Ironclad gold deposit resource at its Barrambie Project to 15,000 ounces, with a significant portion now classified as Indicated, underpinning plans for near-term development.

Telix Pharmaceuticals has announced that Part 1 of its ProstACT Phase 3 trial for TLX591-Tx met its primary safety and dosimetry objectives, with no new safety concerns. The study’s success supports ongoing global enrolment in Part 2 and regulatory engagement in the US.

Micro-X has reached a key development milestone with the completion of its first Full Body CT laboratory test bench, securing a $1.6 million payment from US government partner ARPA-H and advancing its innovative medical imaging program.

Avenira Limited has obtained a $5 million unsecured loan to fund key mining projects and maintain working capital while awaiting a strategic investment approval.